Physician profile
John G Heller
NPI 1528025228
$4,216,915.71
in general payments reported to CMS, 2019-2025
12 companies · $264K in 2025
The $264K reported for 2025 was more than what 97% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786K · 2020: $520K · 2021: $584K · 2022: $688K · 2023: $789K · 2024: $586K · 2025: $264K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.6M · Consulting Fee: $14K · Food and Beverage: $2,352 · Travel and Lodging: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,620,908.00 |
| Consulting Fee | $14,393.00 |
| Food and Beverage | $2,351.99 |
| Travel and Lodging | $924.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,898,018.53 | 2021-2025 | Pyramid +4 Anterior Lumbar Plate System, Centerpiece Plate Fixation System, Cd Horizon Spinal System |
| Medtronic USA, INC. | $1,304,026.80 | 2019-2020 | |
| Stryker Corporation | $11,250.24 | 2019-2023 | Everest Spinal System, N/A, Yukon Oct Spinal System |
| Alphatec Spine, INC | $1,828.69 | 2022-2025 | Other - Miscellaneous |
| Nuvasive, INC. | $395.91 | 2019-2023 | Simplify Cervical Artificial Disc |
| Depuy Synthes Sales INC. | $328.08 | 2019-2025 | Teligen, Symphony |
| Cerapedics INC. | $256.70 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Zimmer Biomet Holdings, INC. | $238.30 | 2019 | |
| Kuros Biosciences USA, INC | $208.26 | 2023-2024 | Magnetos |
| Pacira Pharmaceuticals Incorporated | $203.94 | 2023 | Iovera, Exparel, Zilretta |
| Misonix INC | $96.51 | 2019 | |
| Zimvie INC. | $63.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.